Centanafadine Uses, Dosage, Side Effects and more
Centanafadine is under investigation in clinical trial NCT02827513 (A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects).
| Trade Name | Centanafadine |
| Generic | Centanafadine |
| Centanafadine Other Names | Centanafadine |
| Type | |
| Formula | C15H15N |
| Weight | Average: 209.292 Monoisotopic: 209.120449487 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
